Other Applications for T cell testing

The ultrasensitive Novoleukin Test System is as versatile as the antigen selected to stimulate T cells in blood.

The Novoleukin Test System has excited researchers and drug developers because of its success in celiac disease, positioning it as the first simple clinical test with the necessary sensitivity to reliably detect antigen-specific T cells responsible for common diseases.

Measuring antigen-specific T cells in blood

Research scientists using specialized immunology techniques have been studying antigen-specific T cells for many years because they are the master-control for many immune responses protecting against infections and cancer, induced by vaccines, or causing autoimmune and allergic diseases. 

The Novoleukin Platform is designed for broad application across T cell mediated immune conditions, therapeutic development and vaccine programs.

The Novoleukin test is currently available for research applications in Celiac Disease and Type 1 Diabetes, and can be customized for other antigens and disease applications. Known peptide antigens can be used, or thorough epitope mapping can be performed to identify novel antigens.

Ultrasensitive T cell measurement from a simple blood draw

The Novoleukin Test System standardizes optimal conditions for T cell stimulation and measurement in blood drawn in the clinic, enabling immediate application for clinical research and development when rare antigen-specific T cells are measured in patients.

Autoimmune diseases

Type 1 Diabetes

Multiple Sclerosis

Rheumatoid Arthritis

Oncology

Immuno-oncology

Skin cancer

Gastric cancer

Reaction testing

Food allergy

Environmental allergy

Infectious disease

Type 1 Diabetes

Novoleukin-T1D is in development to measure disease progression and responsiveness to treatments.

We are proud to be supporting the development of the next generation of drugs to modify disease, beyond managing symtoms.

T cell testing specific to your indication

If you are a pharmaceutical or research company developing therapeutics or biomarker monitoring tools for indications where specific disease-associated antigen and T cell responses are implicated, contact us to discuss development of a highly sensitive Novoleukin test system specific to your indication.

Connect with us to explore our pipeline or to discuss innovative applications that advance clinical diagnostics and immune monitoring.